Heart Rate Variability as an Autonomic Marker of Improvement in ME/CFS in a Hydrogen Water Treatment Study
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to predict who will benefit from the hydrogen water treatment. The main questions it aims to answer are: Does the OTC supplement, hydrogen water, work to reduce the fatigue-related symptoms and improve functioning in participants who have ME/CFS? Can HRV be used to predict who will benefit from treatment with hydrogen water?
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
Locations
United States
New York
Stony Brook University
RECRUITING
Stony Brook
Contact Information
Primary
Fred Friedberg, PhD
fred.friedberg@stonybrookmedicine.edu
15167024213
Time Frame
Start Date: 2025-06-09
Estimated Completion Date: 2026-05-31
Participants
Target number of participants: 50
Treatments
Experimental: Hydrogen water standard dosage
The intervention is hydrogen water which is prepared from an OTC supplement. Hydrogen water is a strong anti-oxidant.
Related Therapeutic Areas
Sponsors
Leads: Stony Brook University